Nuvalent garners $135m Series B
Nuvalent Inc, a biotechnology company, has closed $135 million in Series B financing.
Nuvalent Inc, a biotechnology company, has closed $135 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination